Area Soci


Registrati | Recupera password

Pubblicazioni

Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study

Biancone L., Armuzzi A., Scribano ML., D'Inca R., Castiglione F., Papi C., Angelucci E., Daperno M., Mocciaro F., Riegler G., Fries W., Meucci G., Alvisi P., Spina L., Ardizzone S., Petruzziello C., Ruffa A., Kohn A., Vecchi M., Guidi L2, Di Mitri R., Renna S., Emma C., Rogai F., Rossi A., Orlando A., Pallone F.; Italian Group for the study of Inflammatory Bowel Disease

Inter-observer agreement in endoscopic scoring systems: preliminary report of an ongoing study from the Italian Group for Inflammatory Bowel Disease (IG-IBD).

Daperno M, Comberlato M, Bossa F, Biancone L, Bonanomi AG, Cassinotti A, Cosintino R, Lombardi G, Mangiarotti R, Papa A, Pica R, Rizzello F, D'Incà R, Orlando A. Dig Liver Dis. 2014 Nov;46(11):969-73. doi: 10.1016/j.dld.2014.07.010. Epub 2014 Aug 19.

Use of biosimilars in inflammatory bowel disease: Statements of the Italian Group for Inflammatory Bowel Disease.

Annese V, Vecchi M; Italian Group for the Study of IBD (IG-IBD). Dig Liver Dis. 2014 Nov;46(11):963-8. doi: 10.1016/j.dld.2014.07.019. Epub 2014 Aug 17.

Patient and physician views on the quality of care in inflammatory bowel disease: results from SOLUTION-1, a prospective IG-IBD study.

Bortoli A, Daperno M, Kohn A, Politi P, Marconi S, Monterubbianesi R, Castiglione F, Corbellini A, Merli M, Casella G, D'Incà R, Orlando A, Bossa F, Doldo P, Lecis P, Valpiani D, Danese S, Comberlato M; Italian Group for the study of Inflammatory Bowel Disease (IG-IBD). J Crohns Colitis. 2014 Dec 1;8(12):1642-52. doi: 10.1016/j.crohns.2014.07.004. Epub 2014 Aug 10.

The use of biosimilars in immune-mediated disease: A joint Italian Society of Rheumatology (SIR), Italian Society of Dermatology (SIDeMaST), and Italian Group of Inflammatory Bowel Disease (IG-IBD) position paper.

Fiorino G, Girolomoni G, Lapadula G, Orlando A, Danese S, Olivieri I; SIR, SIDeMaST, and IG-IBD. Autoimmun Rev. 2014 Jul;13(7):751-5. doi: 10.1016/j.autrev.2014.02.004. Epub 2014 Mar 19. Review.

Early post-operative endoscopic recurrence in Crohn's disease patients: data from an Italian Group for the study of inflammatory bowel disease (IG-IBD) study on a large prospective multicenter cohort.

Orlando A, Mocciaro F, Renna S, Scimeca D, Rispo A, Lia Scribano M, Testa A, Aratari A, Bossa F, Tambasco R, Angelucci E, Onali S, Cappello M, Fries W, D'Incà R, Martinato M, Castiglione F, Papi C, Annese V, Gionchetti P, Rizzello F, Vernia P, Biancone L, Kohn A, Cottone M. J Crohns Colitis. 2014 Oct 1;8(10):1217-21. doi: 10.1016/j.crohns.2014.02.010. Epub 2014 Mar 11.

Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy.

Monterubbianesi R, Aratari A, Armuzzi A, Daperno M, Biancone L, Cappello M, Annese V, Riegler G, Orlando A, Viscido A, Meucci G, Gasbarrini A, Guidi L, Lavagna A, Sostegni R, Onali S, Papi C, Kohn A; Italian Group for the study of Inflammatory Bowel Disease (IG-IBD). J Crohns Colitis. 2014 Aug 1;8(8):852-8. doi: 10.1016/j.crohns.2014.01.006. Epub 2014 Jan 25.

Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: a prospective, multicenter study.

Meucci G, Fasoli R, Saibeni S, Valpiani D, Gullotta R, Colombo E, D'Incà R, Terpin M, Lombardi G; IG-IBD. Inflamm Bowel Dis. 2012 Jun;18(6):1006-10. doi: 10.1002/ibd.21838. Epub 2011 Aug 9.

Regional variations in the use of complementary and alternative medicines (CAM) for inflammatory bowel disease patients in Italy: an IG-IBD study.

Bertomoro P, Renna S, Cottone M, Riegler G, Bossa F, Giglio L, Pastorelli L, Papi C, Castiglione F, Angelucci E, Pica R, Di Paolo MC, D'Incà R. J Crohns Colitis. 2010 Sep;4(3):291-300. doi: 10.1016/j.crohns.2009.12.009. Epub 2010 Jan 18.

The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease.

Orlando A, Armuzzi A, Papi C, Annese V, Ardizzone S, Biancone L, Bortoli A, Castiglione F, D'Incà R, Gionchetti P, Kohn A, Poggioli G, Rizzello F, Vecchi M, Cottone M; Italian Society of Gastroenterology; Italian Group for the study of Inflammatory Bowel Disease. Dig Liver Dis. 2011 Jan;43(1):1-20. doi: 10.1016/j.dld.2010.07.010. Epub 2010 Sep 16.

Prevalence of celiac disease in inflammatory bowel diseases: An IG-IBD multicentre study.

Casella G, D'Incà R, Oliva L, Daperno M, Saladino V, Zoli G, Annese V, Fries W, Cortellezzi C; Italian Group - IBD. Dig Liver Dis. 2010 Mar;42(3):175-8. doi: 10.1016/j.dld.2009.08.005. Epub 2009 Sep 27.

NOD2/CARD15 in healthy relatives of IBD patients.

Annese V, Latiano A, Palmieri O, Lombardi G, Andriulli A; Italian Group of Inflammatory Bowel Disease. Eur Rev Med Pharmacol Sci. 2006 Jan-Feb;10(1):33-6.

Increased risk of breast cancer in first-degree relatives of Crohn's disease patients. An IG-IBD study.

Riegler G, Caserta L, Castiglione F, Esposito I, Valpiani D, Annese V, Zoli G, Gionchetti P, Viscido A, Sturniolo GC, Rispo A, De Filippo FR, de Leone A, Carratu R; IG-IBD Group. Dig Liver Dis. 2006 Jan;38(1):18-23. Epub 2005 Sep 19.

Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.

Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M. Dig Liver Dis. 2005 Jun;37(6):407-17. Review.

Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease--an IG-IBD study.

Annese V, Lombardi G, Perri F, D'Incà R, Ardizzone S, Riegler G, Giaccari S, Vecchi M, Castiglione F, Gionchetti P, Cocchiara E, Vigneri S, Latiano A, Palmieri O, Andriulli A. Am J Gastroenterol. 2005 Jan;100(1):84-92.

The frame-shift mutation of the NOD2/CARD15 gene is significantly increased in ulcerative colitis: an *IG-IBD study.

Andriulli A, Annese V, Latiano A, Palmieri O, Fortina P, Ardizzone S, Cottone M, D'Inca R, Riegler G. Gastroenterology. 2004 Feb;126(2):625-7. No abstract available. Erratum in: Gastroenterology. 2004 Apr;126(4):1227. Andruilli, A [corrected to Andriulli, A].

Colorectal cancer and high grade dysplasia complicating ulcerative colitis in Italy. A retrospective co-operative IG-IBD study.

Riegler G, Bossa F, Caserta L, Pera A, Tonelli F, Sturniolo GC, Oliva L, Contessini Avesani E, Poggioli G; IG-IBD Group. Dig Liver Dis. 2003 Sep;35(9):628